BWA
CRBU icon

Basecamp Wealth Advisors’s Caribou Biosciences CRBU Stock Holding History

Basecamp Wealth Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65K Hold
937
– – ﹤0.01% 1412
2026
Q1 		$1.78K Hold
937
– – ﹤0.01% 1430
2025
Q4 		$1.49K Buy
+937
New +$1.97K ﹤0.01% 1419

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Basecamp Wealth Advisors's CRBU Position: Q2 2026 in Review

Basecamp Wealth Advisors held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 937 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Basecamp Wealth Advisors first reported a position in CRBU in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.78K in Q1 2026. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Basecamp Wealth Advisors held 937 shares of Caribou Biosciences worth $1.65K as of Q2 2026.
  • Basecamp Wealth Advisors left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1412 holding.
  • Basecamp Wealth Advisors first reported a position in Caribou Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Caribou Biosciences position peaked at $1.78K in Q1 2026.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.